An informal news letter of all kinds of news and comments on the news. Specific intent is to 'track' mergers and acquisitions at the highest levels in our world and the impact these have on individual rights. This blog was started to aid me keep track for my personal benefit. It evolved into a shared content with anyone interested.
Pages
▼
Monday, June 25, 2018
Press Announcements > Statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs in FDA’s Center for Drug Evaluation and Research, on the agency’s response to ongoing drug shortages for critical products
No comments:
Post a Comment